Hereditary Angioedema (HAE)

DBCOND0034226Cardiovascular DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Hereditary Angioedema (HAE) is the indication for 5 drugs in DrugBank. It is covered by 5 curated, structured indications.

Also known as
Hereditary Angioedema · Angioedemas, Hereditary · HAE · Angioedema, Hereditary · Hereditary Angioedema, HAE
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0502559SNOMED CT82966003MedDRA10019860UMLSC0019243

What you can answer from here — as of October 23, 2026

5Indicated drugsWith each drug's targets and mechanism
Listed above
5Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
136Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Contraindicated drugsDrugs whose labels contraindicate them in this condition
Sign in
7Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Hereditary Angioedema (HAE) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In